Liminal BioSciences Inc.: Liminal BioSciences Announces Closing of Sale of Remaining Plasma-Derived Therapeutics Business
LAVAL, QC and CAMBRIDGE, England, Oct. 15, 2021 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that it has closed on the sale